임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

13건 표시

3상모집 예정· Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
리드: 아스트라제네카
상세 →NCT07711002
3상모집 예정· Uncontrolled Hypertension
A Phase IIIb Study to Investigate the Effect of Baxdrostat in Chinese Participants With Uncontrolled Hypertension.
리드: 아스트라제네카
상세 →NCT07686120
3상모집 예정· Hypercholesterolaemia
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With Hypercholesterolaemia
리드: 아스트라제네카
상세 →NCT07619118
3상모집 예정· Advanced Breast Cancer
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
협력: 아스트라제네카
상세 →NCT07683754
3상모집 예정· Renal Insufficiency, Chronic
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
리드: 아스트라제네카
상세 →NCT07624305
3상모집 예정· Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
리드: 아스트라제네카
상세 →NCT07691970
3상모집 예정· Hypercholesterolaemia
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
리드: 아스트라제네카
상세 →NCT07619131
3상모집 예정· Type 2 Diabetes Mellitus
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
리드: 아스트라제네카
상세 →NCT07664553
3상모집 예정· Cardiac Remodeling
Baxdrostat and Ventricular Remodeling
협력: 아스트라제네카
상세 →NCT07655362
3상모집 예정· Asthma
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
리드: 아스트라제네카
상세 →NCT07444567
3상모집 예정· Severe Asthma
Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab
협력: 아스트라제네카
상세 →NCT07013123
3상모집 예정· Asthma
Opening the "Black Box" on Tezepelumab's Effect on Chronic Rhinosinusitis With Severe Asthma
협력: 아스트라제네카
상세 →NCT06740045
3상모집 예정· Superior Sulcus Tumor
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
협력: 아스트라제네카
상세 →NCT04465968

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.